Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis
Status:
Recruiting
Trial end date:
2025-11-15
Target enrollment:
Participant gender:
Summary
Prospective, single arm, single-center clinical study to test NVDX3 in patients suffering
from low grade one level degenerative lumbar (L1 - S1) spondylolisthesis. NVDX3 will be
implanted during a single surgical intervention.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Novadip Biosciences
Collaborators:
Data Investigation Company Europe (DICE) PrimeVigilance